China Looks To Raise Standards As Pharma Ties Up With Large Distributors And Retailers
This article was originally published in PharmAsia News
Executive Summary
Pfizer’s RMB 800 million ($127 million) of annual retail pharmacy sales in China shows the growing potential of the retail channel, and regulators are taking note.